Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE772.754 (+0.52 %)
PREV CLOSE ( ) 768.75
OPEN PRICE ( ) 769.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 100674
TODAY'S LOW / HIGH ( )761.25 778.05
52 WK LOW / HIGH ( )281.15 967.6
NSE772.655 (+0.65 %)
PREV CLOSE( ) 767.65
OPEN PRICE ( ) 768.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 772.65 (1507)
VOLUME 2036809
TODAY'S LOW / HIGH( ) 761.10 778.40
52 WK LOW / HIGH ( )288.85 967.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

26Oct Aurobindo Pharma signs definitive agre
Aurobindo Pharma has signed definitive agreement to sell Natrol, a unit..
26Oct Aurobindo Pharma spurts on signing def
Aurobindo Pharma is currently trading at Rs. 792.80, up by 9.75 points o..
22Oct Aurobindo Pharma’s arm receives warnin
Aurobindo Pharma’s wholly owned step-down subsidiary -- AuroLife Pharma..
22Oct Aurobindo Pharma falls after its arm r
Aurobindo Pharma is currently trading at Rs. 761.70, down by 43.60 point..
22Oct Aurobindo Pharma gets USFDA’s approval
Aurobindo Pharma has received final approval from the US Food & Drug..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit7146.8000000000118727.4
Gross Profit 9601.90000000001 23777
Operating Profit 10904.129437.6
Net Sales 34197132664.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15302.05 (0.92%)
M.Cap ( in Cr)32515.79
Piramal Enterprises (BSE)
peergroup  1261.55 (3.81%)
M.Cap ( in Cr)28452.78
Torrent Pharma (BSE)
peergroup  2564.70 (1.79%)
M.Cap ( in Cr)43396.96
NGL Fine-Chem (BSE)
peergroup  888.65 (5.00%)
M.Cap ( in Cr)549.01
Bajaj Healthcare (BSE)
peergroup  536.45 (7.31%)
M.Cap ( in Cr)740.26

Shareholding Pattern

PROMOTERS 52.01%
NON-INSTITUTION 11.31%
MUTUAL FUNDS/UTI 11.02%
FI/BANKS/INSURANCE 0.17%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 768.75. Its current market capitalisation stands at Rs 45278.41 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes K Nithyananda Reddy, Savita Mahajan, Avnit Bimal Singh, M Sitarama Murty, P V Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)